Evidence map›Paper›PMID 41826696›Full record

ArticleNature cell biology2026

An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelity.

Eric J Aird, Julius Rabl, Tabea Knuesel, Kevin Groen, Samah W Awwad, Boris Korablev, Lynn Scherpe, Waleed Al-Herz, Robin Hupfer, Mike Recher and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Vertebrate Toxin-Antidote System That Sabotages Mouse Embryogenesis.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Eric J AirdInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4873-042X
Julius RablCryo-EM Knowledge Hub, ETH Zurich, Zurich, Switzerland.
Tabea KnueselInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Kevin GroenInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Samah W AwwadCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Boris KorablevInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Lynn ScherpeInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8330-4653
Waleed Al-HerzDepartment of Pediatrics, College of Medicine, Kuwait University, Kuwait City, Kuwait.
Robin HupferImmunodeficiency Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
Mike RecherImmunodeficiency Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9121-6936
Stephen P JacksonCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-9317-7937
Benjamin G HaleInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3891-9480
Jacob E CornInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland. jacob.corn@biol.ethz.ch.ORCID http://orcid.org/0000-0002-7798-5309

Funding

Cancer Research UK (CRUK) DRCPGM\100005Cancer Research UK (CRUK) SEBINT-2024/100003Council for Higher Education of Israel | Israeli Centers for Research Excellence (I-CORE) Outstanding Postdoctoral Women FellowshipEC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 855741-DDREAMM-ERC-2019-SyGEuropean Molecular Biology Organization (EMBO) ALTF 144-2021Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_188858Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 320030_232029Weizmann Institute of Science Women's Postdoctoral Career Development Award in Science
6 · The paper itself

Abstract

Stimulation of the innate immune system by foreign RNA elicits a potent interferon response and can trigger cell death. The mechanisms by which cells balance a robust response with cell-intrinsic lethality are still being uncovered. Here, using genome-wide CRISPR-Cas9 genetic screens with triphosphorylated RNA stimulation, we discover that promyelocytic leukaemia (PML) nuclear body-localized speckled protein 110 (SP110) is a potent inhibitor of type 1 interferon-driven cell death. Death suppression by SP110 counteracts a toxic activity of SP100, a major constituent of PML bodies. Loss of SP110 leads to mitotic retention of SP100 and PML bodies, which associate with and perturb segregating chromosomes, leading to micronucleus formation, DNA damage and genotoxic cell death. A combination of cryo-electron microscopy, AlphaFold modelling and cellular biochemistry reveals that SP110 dissolves toxic SP100 oligomers via necessary and sufficient direct interactions between their caspase activation and recruitment domains. These data reveal the critical roles of SP100 and SP110 in governing the disassembly of PML bodies during mitosis, as well as the repercussions if this process is misregulated.

Indexed as

Antigens, NuclearAutoantigensLeukemia, Promyelocytic, AcuteMitosisNuclear ProteinsPromyelocytic Leukemia ProteinCRISPR-Cas SystemsDNA DamageHumansSignal TransductionAntigens, NuclearAutoantigensNuclear ProteinsPromyelocytic Leukemia ProteinSP100 protein, human

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.